Publication:
Ondokuz Mayıs University Experience in Children with Bone Marrow Failure

dc.contributor.authorSari F.
dc.contributor.authorÖzyürek E.
dc.contributor.authorDuru F.
dc.contributor.authorFişgin T.
dc.contributor.authorAlbayrak C.
dc.contributor.authorOğur G.
dc.contributor.authorAlbayrak D.
dc.date.accessioned2020-06-21T09:36:54Z
dc.date.available2020-06-21T09:36:54Z
dc.date.issued2011
dc.departmentOMÜen_US
dc.department-tempSari, F., Çocuk Sağliği ve Hastaliklari AD, Ondokuz Mayis Üniversitesi Tip Fakültesi, Samsun, Turkey -- Özyürek, E., Hematoloji BD, Ondokuz Mayis Üniversitesi Tip Fakültesi, Samsun, Turkey -- Duru, F., Hematoloji BD, Ondokuz Mayis Üniversitesi Tip Fakültesi, Samsun, Turkey -- Fişgin, T., Hematoloji BD, Ondokuz Mayis Üniversitesi Tip Fakültesi, Samsun, Turkey -- Albayrak, C., Hematoloji BD, Ondokuz Mayis Üniversitesi Tip Fakültesi, Samsun, Turkey -- Oğur, G., Tibbi Genetik AD, Ondokuz Mayis Üniversitesi Tip Fakültesi, Samsun, Turkey -- Albayrak, D., Hematoloji BD, Ondokuz Mayis Üniversitesi Tip Fakültesi, Samsun, Turkeyen_US
dc.description.abstractObjective: There are different registry and research centers for every bone marrow failure syndromes (BMFS), and most of these centers work internationally and give their results periodically. In Turkey, studies about BMFS are limited to Fanconi aplastic anemia, and the data about other BMFS are limited. In this study, we aimed to document our experience about the children with BMFS. Material and Methods: We retrospectively evaluated the medical records of the children with BMFS followed in ou clinic, in between January 1, 1995 and May 30,2008. We discarded the patients with aplastic anemia secondary to malign infiltrative diseases, chemotherapy and radiotherapy together with patients who did not have enough data in their medical records. Results: Among 41 patients who enrolled to the study, 24 (58.5%) of them was boy, and 17(41.5%) of them was girl. Their age at the time of diagnosis was 5.9 ± 4.8 year, and they were followed up for 3.6 ± 3.1 year. There were 15 (36.6%) Fanconi aplastic anemia, 7 (17%) non-Fanconi aplastic anemia, 5 (12.2%) dyskeratosis congenita, 5 (12.2%) pure red cell aplasia, 5 (12.2%) acquired aplastic anemia, 3 (7.3%) osteopetrozis, and 1 (2.4%) severe congenital neutropenia. Conclusion: In conclusion, the most frequent BMFS seen in children in this part of Turkey is Fanconi aplastic anemia, and other BMFS are seen in decreasing frequency. There are some sort of insufficiencies about the diagnosis and follow up of this patient group as seen in our study. To overcome these problems, we need national multicenter studies about this diseases. Copyright © 2011 by Türkiye Klinikleri.en_US
dc.identifier.endpage231en_US
dc.identifier.issn1300-0381
dc.identifier.issue3en_US
dc.identifier.startpage221en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12712/4605
dc.identifier.volume20en_US
dc.language.isotren_US
dc.relation.journalTurkiye Klinikleri Pediatrien_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAnemia, Aplasticen_US
dc.subjectAnemia, Diamond-Blackfanen_US
dc.subjectChilden_US
dc.subjectDyskeratosis Congenitaen_US
dc.subjectFanconi Anemiaen_US
dc.subjectOsteopetrosisen_US
dc.subjectRed-Cell Aplasia, Pureen_US
dc.titleOndokuz Mayıs University Experience in Children with Bone Marrow Failureen_US
dc.title.alternativeKemik i?liği yetmezlikli çocuklarda Ondokuz Mayis ÜNiversitesi deneyimien_US
dc.typeArticleen_US
dspace.entity.typePublication

Files